Daytona Street Capital’s Bristol-Myers Squibb BMY Stock Holding History

Daytona Street Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Sell	21,587 -200	-0.9%	-$11.5K	0.91%	31
2026 Q1	$1.35M	Sell	21,787 -3,460	-14%	-$202K	1.04%	28
2025 Q4	$1.36M	Buy	+25,247	New	+$1.21M	1.06%	29

Other funds holding BMY

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Daytona Street Capital's BMY Position: Q2 2026 in Review

Daytona Street Capital reduced its Bristol-Myers Squibb (BMY) stake by 0.92% in Q2 2026, selling an estimated $11.5K and leaving 21,587 shares worth $1.24M. The position accounts for 0.91% of the portfolio, ranked #31.

Daytona Street Capital first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.36M in Q4 2025. 1,507 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Daytona Street Capital held 21,587 shares of Bristol-Myers Squibb worth $1.24M as of Q2 2026.
Daytona Street Capital sold 200 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5K.
Bristol-Myers Squibb made up 0.91% of Daytona Street Capital's portfolio in Q2 2026, its #31 holding.
Daytona Street Capital first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
Daytona Street Capital's Bristol-Myers Squibb position peaked at $1.36M in Q4 2025.
1,507 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Daytona Street Capital's 13F filing for Q2 2026, filed 3 Aug 2026.